Your browser doesn't support javascript.
loading
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Heuser, Michael; Freeman, Sylvie D; Ossenkoppele, Gert J; Buccisano, Francesco; Hourigan, Christopher S; Ngai, Lok Lam; Tettero, Jesse M; Bachas, Costa; Baer, Constance; Béné, Marie-Christine; Bücklein, Veit; Czyz, Anna; Denys, Barbara; Dillon, Richard; Feuring-Buske, Michaela; Guzman, Monica L; Haferlach, Torsten; Han, Lina; Herzig, Julia K; Jorgensen, Jeffrey L; Kern, Wolfgang; Konopleva, Marina Y; Lacombe, Francis; Libura, Marta; Majchrzak, Agata; Maurillo, Luca; Ofran, Yishai; Philippe, Jan; Plesa, Adriana; Preudhomme, Claude; Ravandi, Farhad; Roumier, Christophe; Subklewe, Marion; Thol, Felicitas; van de Loosdrecht, Arjan A; van der Reijden, Bert A; Venditti, Adriano; Wierzbowska, Agnieszka; Valk, Peter J M; Wood, Brent L; Walter, Roland B; Thiede, Christian; Döhner, Konstanze; Roboz, Gail J; Cloos, Jacqueline.
Afiliación
  • Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Freeman SD; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Ossenkoppele GJ; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Buccisano F; Department of Biomedicine and Prevention, Hematology, University Tor Vergata, Rome, Italy.
  • Hourigan CS; Laboratory of Myeloid Malignancy, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD.
  • Ngai LL; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Tettero JM; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Bachas C; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Baer C; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Béné MC; Department of Hematology and Biology, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France.
  • Bücklein V; Department of Medicine III, University Hospital, Ludwig Maximilian University Munich, Munich, Germany.
  • Czyz A; Department of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Denys B; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University.
  • Dillon R; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Feuring-Buske M; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Guzman ML; Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY.
  • Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Han L; Department of Leukemia and.
  • Herzig JK; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Jorgensen JL; The Department of Hematopathology, MD Anderson Cancer Center, Houston, TX.
  • Kern W; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Konopleva MY; Department of Leukemia and.
  • Lacombe F; Hematology Biology, Flow Cytometry, Bordeaux University Hospital, Pessac, France.
  • Libura M; Medical University of Warsaw, Warsaw, Poland.
  • Majchrzak A; Department of Experimental Hematology, Copernicus Memorial Hospital, Lodz, Poland.
  • Maurillo L; Department of Biomedicine and Prevention, Hematology, University Tor Vergata, Rome, Italy.
  • Ofran Y; Department of Hematology, Shaare Zedek Medical Center Faculty of Medicine Hebrew University, Jerusalem Israel.
  • Philippe J; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University.
  • Plesa A; Department of Hematology Laboratory, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France.
  • Preudhomme C; Laboratory of Hematology, CHU Université de Lille, Lille, France.
  • Ravandi F; Department of Leukemia and.
  • Roumier C; Laboratory of Hematology, CHU Université de Lille, Lille, France.
  • Subklewe M; Department of Medicine III, University Hospital, Ludwig Maximilian University Munich, Munich, Germany.
  • Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • van der Reijden BA; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Venditti A; Department of Biomedicine and Prevention, Hematology, University Tor Vergata, Rome, Italy.
  • Wierzbowska A; Department of Hematology, Medical University of Lodz, Lodz, Poland.
  • Valk PJM; Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Wood BL; Department of Hematopathology, Children's Hospital Los Angeles, CA.
  • Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Thiede C; Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany; and.
  • Döhner K; AgenDix GmbH, Dresden, Germany.
  • Roboz GJ; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Cloos J; Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY.
Blood ; 138(26): 2753-2767, 2021 12 30.
Article en En | MEDLINE | ID: mdl-34724563
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasia Residual Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasia Residual Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos